Cabaletta Bio (CABA) Cash from Financing Activities (2018 - 2025)
Cabaletta Bio (CABA) recorded Cash from Financing Activities of $8.33 million in Q4 2025, up 90.6% from $4.37 million a year earlier.
Powered by 
Analysis
Cabaletta Bio (CABA) Cash from Financing Activities (2018 - 2025) Analysis & Trends
For FY2025, Cabaletta Bio reported Cash from Financing Activities of $100.35 million, up 759.4% from FY2024.
- Across earlier years, Cash from Financing Activities came in at $11.68 million in FY2024 (-93.8%), $187.63 million in FY2023 (+468.9%), $32.98 million in FY2022 (-32.6%) and $48.9 million in FY2021.
- Quarterly Cash from Financing Activities has ranged from -$806,000 in Q3 2025 to $94.26 million in Q2 2023 over the past five years.
- On a year-over-year basis, Cash from Financing Activities rose in 1 of the last four quarters, with an average decline of 33.0%.
- Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 343.1% in Q1 2023, against a decline of 99.6% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -$806,000 (Q3 2025), $93.37 million (Q2 2025) and -$552,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Cabaletta Bio | 325.53 Mn | 325.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.33 Mn |
| Sep 30, 2025 | -806,000.00 |
| Jun 30, 2025 | 93.37 Mn |
| Mar 31, 2025 | -552,000.00 |
| Dec 31, 2024 | 4.37 Mn |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Mar 31, 2024 | 6.86 Mn |
| Dec 31, 2023 | 93.05 Mn |
| Sep 30, 2023 | 98,000.00 |
| Jun 30, 2023 | 94.26 Mn |
| Mar 31, 2023 | 226,000.00 |
| Dec 31, 2022 | 32.89 Mn |
| Jun 30, 2022 | 40,000.00 |
| Mar 31, 2022 | 51,000.00 |
| Dec 31, 2021 | 13.63 Mn |
| Sep 30, 2021 | 25.34 Mn |
| Jun 30, 2021 | 7.77 Mn |
| Mar 31, 2021 | 2.17 Mn |
| Dec 31, 2020 | 32,000.00 |
API Access
Cabaletta Bio Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CABA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "CABA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CABA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();